Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) rats.
Prukop T, Wernick S, Boussicault L, Ewers D, Jäger K, Adam J, Winter L, Quintes S, Linhoff L, Barrantes-Freer A, Bartl M, Czesnik D, Zschüntzsch J, Schmidt J, Primas G, Laffaire J, Rinaudo P, Brureau A, Nabirotchkin S, Schwab MH, Nave KA, Hajj R, Cohen D, Sereda MW.
Prukop T, et al. Among authors: schwab mh.
J Neurosci Res. 2020 Oct;98(10):1933-1952. doi: 10.1002/jnr.24679. Epub 2020 Jun 26.
J Neurosci Res. 2020.
PMID: 32588471